Treatment of osteonecrosis of the jaw (ONJ) by medical ozone gas insufflation. A case report.

Osteonecrosis of the jaw (ONJ) is an adverse event reported in patients receiving cancer treatment, especially bisphosphonates and denosumab. A patient with multiple myeloma who underwent up to 22 intravenous zoledronic acid infusions without previous dental examination developed a devastating ONJ lesion in the right horizontal mandibular ramus. He was treated with local ozone gas applications every third day by means of a special bell to avoid O(3) diffusion. Azithromycin 500 mg/day was administered for 10 days prior to the O(3) applications. O(3) therapy resulted in sequestration of the necrotic bone after a median of 15 applications, following which surgery was necessary to remove it. Interestingly, removal was possible without the resection of the healthy mandible edge because of the presence of the bone sequestrum. Medical O(3) gas administration was effective and safe in a patient treated with bisphosphonates who developed a >2.5 cm ONJ lesion. Future research is needed to demonstrate the efficacy and tolerability of such treatment in a larger number of patients.

[1]  K. McKeage,et al.  Zoledronic Acid , 2012, PharmacoEconomics.

[2]  L. Mariani,et al.  Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study. , 2011, Oral oncology.

[3]  G. Morgan,et al.  Antitumor effects and anticancer applications of bisphosphonates. , 2010, Seminars in oncology.

[4]  C. Brunelli,et al.  Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  M. Dimopoulos,et al.  Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  M. Petrucci,et al.  Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients , 2007, Haematologica.

[7]  E. Eriksen,et al.  Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients--May 2006. , 2007, Critical reviews in oncology/hematology.

[8]  J. Kalmar,et al.  Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws , 2006, Annals of Internal Medicine.

[9]  D. Colville,et al.  Letter from Deb Colville and colleagues: women doctors , 2003 .